Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04919226 |
|---|---|
| Brief Title: | Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE (COMPOSE) |
| First Submitted : | June 1, 2021 |
| First Submitted that Met QC Criteria : | June 8, 2021 |
| First Posted : | June 9, 2021 |
| Last Update Submitted that Met QC Criteria : | April 5, 2024 |
| Last Update Posted : | April 8, 2024 |